Literature DB >> 11519050

Elevated expression of vacuolar proton pump genes and cellular PH in cisplatin resistance.

T Murakami1, I Shibuya, T Ise, Z S Chen, S Akiyama, M Nakagawa, H Izumi, T Nakamura, K Matsuo , Y Yamada, K Kohno.   

Abstract

V-ATPases are proton-translocating enzymes, which are found not only in numerous intracellular organelles but also in the plasma membranes of many eukaryotic cells. Using differential display, we have identified one of the proton pump subunit genes, ATP6C, as a cisplatin-inducible gene. Northern blot analysis demonstrated that expression of other members of the subunit is inducible by cisplatin treatment. Proton pump gene expression is also upregulated in 3 independent cisplatin-resistant cell lines but not in vincristine- or etoposide-resistant cell lines. Cellular pH was significantly higher in cisplatin-resistant cells than in sensitive parental cells. In vitro DNA-binding activity of cisplatin was markedly increased in acidic conditions, suggesting that the cytotoxicity of cisplatin is modulated by cellular pH. Furthermore, the proton pump inhibitor bafilomycin can synergistically potentiate the cytotoxicity of cisplatin but not of etoposide or camptothecin. These results indicate that cellular pH is one of the critical parameters for effective cancer chemotherapy with cisplatin. Copyright 2001 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11519050     DOI: 10.1002/ijc.1418

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  43 in total

1.  Function of a subunit isoforms of the V-ATPase in pH homeostasis and in vitro invasion of MDA-MB231 human breast cancer cells.

Authors:  Ayana Hinton; Souad R Sennoune; Sarah Bond; Min Fang; Moshe Reuveni; G Gary Sahagian; Daniel Jay; Raul Martinez-Zaguilan; Michael Forgac
Journal:  J Biol Chem       Date:  2009-04-14       Impact factor: 5.157

2.  Resistance mechanisms of cancer cells to the novel vacuolar H(+)-ATPase inhibitor archazolid B.

Authors:  Rebecca Hamm; Yoshikazu Sugimoto; Heinrich Steinmetz; Thomas Efferth
Journal:  Invest New Drugs       Date:  2014-07-29       Impact factor: 3.850

3.  Selective inhibition of tumor cell associated Vacuolar-ATPase 'a2' isoform overcomes cisplatin resistance in ovarian cancer cells.

Authors:  Arpita Kulshrestha; Gajendra K Katara; Jordyn Ginter; Sahithi Pamarthy; Safaa A Ibrahim; Mukesh K Jaiswal; Corina Sandulescu; Ramayee Periakaruppan; James Dolan; Alice Gilman-Sachs; Kenneth D Beaman
Journal:  Mol Oncol       Date:  2016-01-29       Impact factor: 6.603

Review 4.  Nanoscale drug delivery platforms overcome platinum-based resistance in cancer cells due to abnormal membrane protein trafficking.

Authors:  Xue Xue; Matthew D Hall; Qiang Zhang; Paul C Wang; Michael M Gottesman; Xing-Jie Liang
Journal:  ACS Nano       Date:  2013-12-10       Impact factor: 15.881

5.  Reduced endocytosis and altered lysosome function in cisplatin-resistant cell lines.

Authors:  S S Chauhan; X J Liang; A W Su; A Pai-Panandiker; D W Shen; J A Hanover; M M Gottesman
Journal:  Br J Cancer       Date:  2003-04-22       Impact factor: 7.640

Review 6.  Proton pump inhibitors as anti vacuolar-ATPases drugs: a novel anticancer strategy.

Authors:  Enrico P Spugnini; Gennaro Citro; Stefano Fais
Journal:  J Exp Clin Cancer Res       Date:  2010-05-08

7.  p300/CBP-associated factor (P/CAF) interacts with nuclear respiratory factor-1 to regulate the UDP-N-acetyl-alpha-d-galactosamine: polypeptide N-acetylgalactosaminyltransferase-3 gene.

Authors:  Hiroto Izumi; Ryo Ohta; Gunji Nagatani; Tomoko Ise; Yoshifumi Nakayama; Minoru Nomoto; Kimitoshi Kohno
Journal:  Biochem J       Date:  2003-08-01       Impact factor: 3.857

8.  Influence of extracellular pH on the cytotoxicity, cellular accumulation, and DNA interaction of novel pH-sensitive 2-aminoalcoholatoplatinum(II) complexes.

Authors:  Seied Mojtaba Valiahdi; Alexander E Egger; Walter Miklos; Ute Jungwirth; Kristof Meelich; Petra Nock; Walter Berger; Christian G Hartinger; Markus Galanski; Michael A Jakupec; Bernhard K Keppler
Journal:  J Biol Inorg Chem       Date:  2013-01-26       Impact factor: 3.358

Review 9.  V-ATPase functions in normal and disease processes.

Authors:  Ayana Hinton; Sarah Bond; Michael Forgac
Journal:  Pflugers Arch       Date:  2007-11-20       Impact factor: 3.657

Review 10.  The Function of V-ATPases in Cancer.

Authors:  Laura Stransky; Kristina Cotter; Michael Forgac
Journal:  Physiol Rev       Date:  2016-07       Impact factor: 37.312

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.